Delivery Order SPE2DB22D2206-SPE2DB23FJS65
Award Date 8/10/23
Potential Completion Date 8/31/23
Potential Value $108K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $56,490.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the pharmaceutical Revlimid 10 mg. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is from August 18, 2023 through September 11, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order supports DLA's mission to provide critical...
- The Defense Logistics Agency awarded a $14,122.63 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the pharmaceutical Revlimid 10 mg. The order is being fulfilled under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the Revlimid capsules to a facility in Conshohocken, Pennsylvania by September 12, 2023 to support DLA and DoD medical readiness...
- The Defense Logistics Agency awarded a $14,122 delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the pharmaceutical REVLIMID 10 MG. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania for delivery by August 22, 2023 in support of DLA programs. As a top 100 Defense Department contractor, Amerisourcebergen will likely distribute the medication through its commercial supply chain to military treatment facilities and...
- The Defense Logistics Agency awarded a $108,000 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 capsules of the pharmaceutical Revlimid 25 mg. The contract has a firm fixed price and calls for delivery to a facility in Conshohocken, Pennsylvania by mid-October 2023. Amerisourcebergen will serve as the prime contractor to fulfill this requirement for the prescription drug under the Agency's logistics support programs. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a delivery order valued at $12,993.03 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (quantity: 28 units). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of December 12, 2025. The pharmaceutical supply will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately ninety-five thousand dollars to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide one hundred capsules of the pharmaceutical Revlimid to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three week period concluding in early August. As the prime contractor,...
- The Defense Logistics Agency awarded a delivery order valued at $51,681.12 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a $171,284.14 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 10mg capsules of the pharmaceutical drug REVLIMID. The order was placed under an existing contract, with no set-aside designation, and the place of performance is Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a prime contractor that has received numerous awards from DLA to supply pharmaceuticals,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at fourteen thousand two hundred thirty-five dollars and fifty-six cents ($14,235.56) to Amerisourcebergen Drug Corporation for the provision of five milligram Revlimid capsules. Under the terms of the contract, Amerisourcebergen will deliver twenty-eight (28) capsules to the agency's location in Conshohocken, Pennsylvania between July 18 and August 8, 2023. As the prime contractor, Amerisourcebergen will be...
- The Defense Logistics Agency awarded a delivery order valued at $19,176.36 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) on January 23, 2026, with a completion date of February 13, 2026. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The contractor's place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp is a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FJS65Delivery Order
The Defense Logistics Agency awarded a $107,912 delivery order to Amerisourcebergen Drug Corporation for the provision of 100 capsules of the pharmaceutical Revlimid 10 mg. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by August 31, 2023 in support of DLA's pharmaceutical procurement programs. As the prime contractor, Amerisourcebergen Corporation will deliver the requested pharmaceutical supplies through its Amerisourcebergen Drug Corporation division. No subcontractors or set aside designations were indicated in the award information.
Generated 12/23/23, 3:14 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $107.9k | 8/10/23 |